Seed Funding vs Growth Funding

Short answer: seed funding backs a company before the model is proven, betting mostly on the team and the problem, in checks that fund product and first customers. Growth funding backs a company that has already demonstrated meaningful traction, with larger checks aimed at scaling the business and expanding its market position. Seed funding gives a company the resources to prove its core assumptions. Pitango invests across both stages, through Pitango First at seed and early stage and Pitango Growth at later stages.

Founders sometimes approach a growth investor with a seed-stage story, or a seed fund with a round that falls well outside its typical investment range. Understanding what each stage funds, and what each investor examines, helps founders focus their time on the investors most relevant to their stage.

What is seed funding, and which companies suit it?

Seed is often one of the first institutional rounds in a company, and it usually arrives when the product is early or still forming. The round pays for building the product, hiring the first few people, and testing whether the product solves a real problem for its intended market.

A seed investor is buying into uncertainty on purpose. Much is still unproven, so the decision rests on the founders, the size of the problem, and whatever early signal exists: a prototype in use, a pilot inside one organization, a waitlist that keeps growing without paid acquisition.

Companies that fit seed tend to share a few traits:

• A team with real depth in the field, technical or commercial.
• A problem large enough that solving it creates a company rather than a feature.
• Some early proof, even a rough one, that customers or users need the solution.
• A clear use for the capital, with meaningful milestones for what it should enable.

At seed, credibility matters more than polish. A rough prototype that customers keep using can be a stronger signal than a polished deck describing a product nobody has tried.

What is growth funding, and when is a company ready for it?

Growth funding typically arrives once a company has demonstrated that its model can scale. Depending on the sector, that may mean a growing customer base, recurring revenue, strong retention, commercial partnerships, or other clear evidence that the company is ready to scale. The money pays for scale: entering new markets, building out the organization, expanding product capabilities, making strategic acquisitions, or preparing for the company’s next stage of growth.

At the growth stage, investors typically expect substantial evidence of commercial traction, although what that looks like varies significantly by sector. A growth investor is evaluating an existing business rather than an early hypothesis, so the quality and predictability of the company’s data become much more important. The exact threshold varies by sector. For recurring-revenue businesses, strong retention and predictable revenue will generally provide a stronger growth signal than the same level of revenue built primarily on one-off projects.

Readiness usually shows up as a set of facts rather than a feeling. Depending on the business, those may include efficient customer acquisition, strong retention, growing demand, a leadership team beyond the founders, and clear evidence that additional capital can accelerate growth.

What do investors evaluate at each stage?

The two conversations barely resemble each other.

Can the same fund invest across multiple stages?

Yes, and there’s real value in the continuity. An existing investor already knows the company’s history, the team, and the decisions that brought it to this point, which can add valuable context as the company moves into its next stage. That continuity also means the relationship and shared context can build over time rather than starting again with every round.

Pitango invests at every stage through three funds. Pitango First invests in seed and early-stage companies across areas including AI, infrastructure, cybersecurity, and quantum computing. Pitango HealthTech invests in early-stage companies across digital health, medical devices, clinical innovation, FemTech, and pharma. Pitango Growth backs later-stage companies scaling toward category leadership. This structure gives Pitango the ability to support companies across different stages of their journey, with relationships that can develop over many years.

The right investor at seed should bring value for the company you’re building today, while understanding the company you have the potential to become.

Building a bold, global tech company and thinking about your next funding round? Reach out directly at pitango@pitango.com.